Guosheng S. Fu

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 257 publications

Polyporus umbellatus β-glucan ameliorates metabolic dysfunction-associated steatohepatitis by remodeling the gut microbiota-bile acid-FXR signaling axis.

Polyporus umbellatus β-glucan ameliorates metabolic dysfunction-associated steatohepatitis by remodeling the gut microbiota-bile acid-FXR signaling axis.

Journal: Journal of ethnopharmacology

Published: June 06, 2026

Thermally driven self-assembly of triterpenoid-fructan supramolecular particles contributes significantly to the efficacy of Zexie Tang against MASH.

Thermally driven self-assembly of triterpenoid-fructan supramolecular particles contributes significantly to the efficacy of Zexie Tang against MASH.

Journal: Carbohydrate polymers

Published: March 22, 2026

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial.

Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial.

Journal: Circulation

Published: March 19, 2026

Clinical Validation of a Novel Pressure Microcatheter-Based Nonhyperemic Pressure Ratio (SUPREME II Study).

Clinical Validation of a Novel Pressure Microcatheter-Based Nonhyperemic Pressure Ratio (SUPREME II Study).

Journal: Journal of the American Heart Association

Published: March 13, 2026

Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial.

Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial.

Journal: Journal of the American College of Cardiology

Published: February 28, 2026

Open-Irrigated Helical Radiofrequency Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

Open-Irrigated Helical Radiofrequency Septal Ablation for Obstructive Hypertrophic Cardiomyopathy.

Journal: JACC. Case reports

Published: February 16, 2026

Cardiomyocyte-derived OTUD7B promotes cardiac hypertrophy by deubiquitinating SERCA2a.

Cardiomyocyte-derived OTUD7B promotes cardiac hypertrophy by deubiquitinating SERCA2a.

Journal: Theranostics

Published: November 27, 2025

Immune-integrated cardiac fibrosis-on-a-chip: a 3D microfluidic device for region-specific immune-cardiac crosstalk in the fibrotic heart.

Immune-integrated cardiac fibrosis-on-a-chip: a 3D microfluidic device for region-specific immune-cardiac crosstalk in the fibrotic heart.

Journal: Lab on a chip

Published: October 29, 2025

Spatiotemporal reprogramming of cardiac lipid metabolism by platelet-engineered RNA therapy epigenetically modulate heart repair and regeneration.

Spatiotemporal reprogramming of cardiac lipid metabolism by platelet-engineered RNA therapy epigenetically modulate heart repair and regeneration.

Journal: Bioactive materials

Published: October 16, 2025

Dual-biomimetic Nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repair.

Dual-biomimetic Nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repair.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 16, 2025

Post-PCI Global QFR and Long-Term Outcomes in ACS: Findings From the FAVOR III China Trial.

Post-PCI Global QFR and Long-Term Outcomes in ACS: Findings From the FAVOR III China Trial.

Journal: JACC. Cardiovascular interventions

Published: October 12, 2025

Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II).

Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II).

Journal: Journal of the American College of Cardiology

Published: September 28, 2025

Showing 1-12 of 257

Last Updated: 09/26/2026